Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling

Alzheimer's disease (AD) is a progressive neurodegenerative disorder which affects cognitive functions with negative impact on day to day activities and an ultimate loss of independent living. Current standard of care (SOC) for AD, viz. donepezil, rivastigmine, galantamine, memantine etc. eithe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2023-05, Vol.947, p.175625-175625, Article 175625
Hauptverfasser: Nirogi, Ramakrishna, Grandhi, Venkata Ramalingayya, Medapati, Rajeshbabu, Ganuga, Narender, Abraham, Renny, Thentu, Jagadeesh Babu, Palacharla, Veera Raghava Chowdary, Petlu, Surendra, Srirangavaram, Maheshwari, Subramanian, Ramkumar, Ravella, Srinivasa Rao, Gagginapally, Shankar Reddy, Benade, Vijay, Jayarajan, Pradeep, Mohammed, Abdul Rasheed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!